Skip to main content
OpenTrials

Clinical trial condition

Ovarian Neoplasms

Explore clinical trials studying Ovarian Neoplasms. Study availability and eligibility vary by location and protocol.

194 public trials 42 recruiting studies
Refine in advanced search Browse all conditions

Ovarian Neoplasms trial results

Completed

A Study of Niraparib Combined With Bevacizumab Maintenance Treatment in Participants With Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based Chemotherapy

NCT03326193

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +12 more
Locations
  • GSK Investigational Site Mobile, Alabama, United States
  • GSK Investigational Site Anchorage, Alaska, United States
  • GSK Investigational Site Mesa, Arizona, United States
  • GSK Investigational Site Burbank, California, United States
View all 29 locations
View Trial Details
Completed

A Study to Evaluate the Efficacy and Safety of Novel Treatment Combinations in Participants With Ovarian Cancer

NCT03574779

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +12 more
Locations
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Los Angeles, California, United States
  • GSK Investigational Site San Francisco, California, United States
  • GSK Investigational Site Stanford, California, United States
View all 28 locations
View Trial Details
Completed

An Interventional Study of Avastin (Bevacizumab) in Patients With Advanced/Metastatic Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

NCT01932125

Conditions
Abdominal Neoplasms, Adnexal Diseases, Digestive System Diseases, +19 more
Locations
  • Manipal Hospital Bangalore, Karnataka, India
  • HealthCare Global Enterprises Limited Banglore, Karnataka, India
  • Marthwada Regional Cancer Center & Research Institute Aurangabad, Maharashtra, India
  • MOC Cancer Care & Research Centre Mumbai, Maharashtra, India
View all 13 locations
View Trial Details
Completed

Cancer Loyalty Card Study

NCT03994653

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +12 more
Locations
  • Imperial College Healthcare NHS Trust London, United Kingdom
View Trial Details
Completed

Best Approach in Recurrent-Ovarian-Cancer-with Cediranib-Olaparib

NCT03314740

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +12 more
Locations
  • Spedali Civili di Brescia Brescia, BS, Italy
  • Ospedale San Gerardo - ASST Monza Monza, MB, Italy
  • Istituto Oncologico Veneto (IOV) Padova, PD, Italy
  • Arcispedale Santa Maria Nuova Reggio Emilia, RE, Italy
View Trial Details

Related conditions